Philips To Acquire SpectraWAVE, Expanding AI-Powered Coronary Imaging And Physiological Assessment Portfolio; Deal Terms Not Disclosed
Benzinga Newsdesk 11 months ago
M&ANews
Acquisition of SpectraWAVE's next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR,
- Acquisition of SpectraWAVE's next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1]
- SpectraWAVE's technologies have the potential to significantly increase adoption of coronary intravascular imaging and physiological assessment, especially when combined with Philips' industry-leading Azurion image-guided therapy platform, supporting better outcomes [2] for more cardiac patients
- Acquisition will expand Philips' existing intravascular imaging and physiological assessment device portfolio, featuring Eagle Eye Platinum digital IVUS and OmniWire iFR technology, to create a comprehensive offering in intravascular imaging and physiology solutions